FILTER

Refine your search with the following facets to narrow down your results.

473 Current news about the topic biotechnology

Avecia expands cell expression with XOMA technology

11-Jun-2001 - Avecia today announced further expansion of the gene expression tool-kit of its Biotechnology contract manufacturing business with the licensing of the patented technology of XOMA Ltd. (Nasdaq:XOMA) for protein-based bio-pharmaceuticals production. Avecia will use XOMA’s bacterial cell ...

bases biologics biopharmaceuticals +7

Sartorius Relocates the Head Office of Its Biotechnology Subsidiary Vivascience to the Medical Park in Hanover, Germany

05-Jun-2001 - Sartorius AG’s biotechnology subsidiary, Vivascience Limited, will be included in Vivascience AG so that the headquarters of this subsidiary is, in fact, being relocated from Lincoln, England to Hanover, Germany. This decision marks Sartorius’ commitment to Lower Saxony as a viable business ...

Beiersdorf biology biotechnology +8

Henkel acquires stake in biotechnology company

25-May-2001 - The Henkel Group has acquired a minority interest in Natural Implant, a biotechnology company established two years ago in Lyon, France. After Vermicon, Natural Implant is the second biotechnology company in which Henkel has taken a minority shareholding. Natural Implant has expertise in ...

biotechnology cell culturing Henkel

Biogen Selects Denmark's 'Medicon Valley' as Site for its First International Major Manufacturing Facility

16-May-2001 - Biogen, Inc. (Nasdaq: BGEN) today announced that it has purchased a 60-acre (243,000 m2) site with an option for an additional 36 acres (145,692 m2) in the Municipality of Hillerod, Denmark as the site of its first European major manufacturing facility. Biogen plans to invest $350 million or ...

Biogen biologics biotechnology +5

Dow and University of Stuttgart Form Research Collaboration

15-May-2001 - The Dow Chemical Company and the University of Stuttgart have announced a long-range collaborative research program targeting the improvement of environmental profiles for some plastics, more sustainable industrial processes and new biocatalytic processes to produce pharmaceuticals. Contingent ...

Applied Research biocatalysis biochemistry +11

DuPont Makes Key Polymer Ingredient from Corn Instead of Petroleum

03-May-2001 - WILMINGTON, Del., May 1, 2001 - DuPont has successfully manufactured a critical ingredient for its newest polymer, Sorona[tm], using a fermentation process based on corn sugar, a renewable resource. Before this development, the substance could only be produced from petrochemicals. The ...

biology biotechnology Degussa +8

Serono and Evotec OAI sign assay development and screening services agreement

27-Apr-2001 - Serono S.A. (SWX Swiss Exchange: SEO and NYSE: SRA) has announced a services agreement with Evotec OAI, Hamburg, Germany (EVOTEC BioSystems AG, Neuer Markt: EVT), a supplier of integrated high-value added biological, chemical and screening programmes to the pharmaceutical and biotechnology ...

biology biotechnology combinatorial chemistry +5

Akzo Nobel’s business unit Diosynth establishes biotech bridgehead in the US

25-Apr-2001 - Akzo Nobel announced today that its Pharma business Diosynth will acquire Covance Biotechnology Services Inc. (CBSI) for EUR 210 million (USD 190 million). CBSI is a leading company in the development and manufacturing of innovative biopharmaceutical substances, with an estimated sales volume ...

active pharmaceutical ingredients Akzo Nobel bases +4

PPD Launches PPD DirectConnect(TM), Unique Secured Client Web Portal For Clinical Trial Project Management

17-Apr-2001 - PPD, Inc. (Nasdaq: PPDI) today launched PPD DirectConnect(TM), a customizable suite of secure, Web-based project management tools, giving clients online access to the latest data from their clinical trials. Through the PPD DirectConnect platform, PPD can now offer clients a secured Web site ...

biotechnology clinical trials informatics +3

Roche: Japan approves breakthrough breast cancer drug

05-Apr-2001 - Women with advanced breast cancer in Japan will soon be able to receive Herceptin after the approval by health authorities in Tokyo. Herceptin is already approved for the treatment of metastatic (advanced) breast cancer in over 60 countries around the world. Regulatory approval in Japan ...

Argentina biotechnology Brazil +12